CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
CRISPR Therapeutics (CRSP) stock has been pushing downwards in recent weeks, taking it near a 52-week low. The stock’s fall likely reflects the broader selloff and rotation away from technology stoc...